Eun-Sil Sung

481 total citations
14 papers, 262 citations indexed

About

Eun-Sil Sung is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Eun-Sil Sung has authored 14 papers receiving a total of 262 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Eun-Sil Sung's work include Cell death mechanisms and regulation (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Eun-Sil Sung is often cited by papers focused on Cell death mechanisms and regulation (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Eun-Sil Sung collaborates with scholars based in South Korea, China and Canada. Eun-Sil Sung's co-authors include Yong‐Sung Kim, Young‐Don Lee, Se-Ho Kim, Ki-Su Kim, Seok-Ki Kim, Tae Hwan Shin, Ye‐Jin Kim, Weon‐Kyoo You, Myung‐Hee Kwon and Chul‐Ho Kim and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and Experimental Cell Research.

In The Last Decade

Eun-Sil Sung

14 papers receiving 254 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eun-Sil Sung South Korea 10 186 92 84 54 29 14 262
Angéla Virone-Oddos France 11 185 1.0× 81 0.9× 144 1.7× 89 1.6× 13 0.4× 30 376
Katharina Jannasch Germany 8 186 1.0× 30 0.3× 124 1.5× 49 0.9× 66 2.3× 10 341
Gilda Rossoni Italy 7 128 0.7× 38 0.4× 167 2.0× 41 0.8× 32 1.1× 17 338
Anna Lyakisheva Canada 7 211 1.1× 27 0.3× 45 0.5× 31 0.6× 18 0.6× 11 299
Seung‐Oe Lim United States 8 152 0.8× 25 0.3× 146 1.7× 138 2.6× 46 1.6× 10 287
Katharina Wartha Switzerland 5 105 0.6× 68 0.7× 124 1.5× 164 3.0× 22 0.8× 7 276
L D Apelgren United States 9 166 0.9× 158 1.7× 132 1.6× 100 1.9× 23 0.8× 11 333
Yasuo Sekimori Japan 4 250 1.3× 240 2.6× 96 1.1× 116 2.1× 13 0.4× 6 382
Eric Kielhorn United States 6 246 1.3× 17 0.2× 121 1.4× 49 0.9× 29 1.0× 7 341
Maya Dadiani Israel 12 201 1.1× 48 0.5× 145 1.7× 46 0.9× 136 4.7× 22 411

Countries citing papers authored by Eun-Sil Sung

Since Specialization
Citations

This map shows the geographic impact of Eun-Sil Sung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eun-Sil Sung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eun-Sil Sung more than expected).

Fields of papers citing papers by Eun-Sil Sung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eun-Sil Sung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eun-Sil Sung. The network helps show where Eun-Sil Sung may publish in the future.

Co-authorship network of co-authors of Eun-Sil Sung

This figure shows the co-authorship network connecting the top 25 collaborators of Eun-Sil Sung. A scholar is included among the top collaborators of Eun-Sil Sung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eun-Sil Sung. Eun-Sil Sung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Gao, Jing, Zhengyi Wang, Wenqing Jiang, et al.. (2023). CLDN18.2 and 4-1BB bispecific antibody givastomig exerts antitumor activity through CLDN18.2-expressing tumor-directed T-cell activation. Journal for ImmunoTherapy of Cancer. 11(6). e006704–e006704. 24 indexed citations
2.
Park, Eun Young, Eun-Sil Sung, Youngeun Hong, et al.. (2021). Abstract 1633: ABL501, PD-L1 x LAG-3, a bispecific antibody promotes enhanced human T cell activation through targeting simultaneously two immune checkpoint inhibitors, LAG-3 and PD-L1. Cancer Research. 81(13_Supplement). 1633–1633. 3 indexed citations
3.
Jiang, Wenqing, Lei Fang, Zhengyi Wang, et al.. (2020). Abstract 5644: Claudin 18.2 X 4-1BB bispecific antibody induced potent tumor inhibition through tumor-specific 4-1BB activation. Cancer Research. 80(16_Supplement). 5644–5644. 2 indexed citations
4.
Lee, Dongheon, Dongin Kim, Eun-Sil Sung, et al.. (2016). Simultaneous blockade of VEGF and Dll4 by HD105, a bispecific antibody, inhibits tumor progression and angiogenesis. mAbs. 8(5). 892–904. 39 indexed citations
5.
You, Weon‐Kyoo, et al.. (2015). Development of antibody-based c-Met inhibitors for targeted cancer therapy. ImmunoTargets and Therapy. 4. 35–35. 24 indexed citations
6.
Shin, Tae Hwan, Eun-Sil Sung, Ye‐Jin Kim, et al.. (2014). Enhancement of the Tumor Penetration of Monoclonal Antibody by Fusion of a Neuropilin-Targeting Peptide Improves the Antitumor Efficacy. Molecular Cancer Therapeutics. 13(3). 651–661. 54 indexed citations
7.
Lee, Bok‐Soon, Yoo Seob Shin, Jae Won Chang, et al.. (2013). Valproic Acid Sensitizes TRAIL-Resistant Anaplastic Thyroid Carcinoma Cells to Apoptotic Cell Death. Annals of Surgical Oncology. 20(S3). 716–724. 10 indexed citations
8.
Kim, Aeyung, et al.. (2012). Interfering transbody-mediated Her2 gene silencing induces apoptosis by G0/G1 cell cycle arrest in Her2-overexpressing SK-BR-3 breast cancer cells. Biotechnology and Bioprocess Engineering. 17(2). 413–419. 2 indexed citations
9.
Lee, Bok‐Soon, Sung Un Kang, Hye Sook Hwang, et al.. (2012). An agonistic antibody to human death receptor 4 induces apoptotic cell death in head and neck cancer cells through mitochondrial ROS generation. Cancer Letters. 322(1). 45–57. 15 indexed citations
10.
11.
Sung, Eun-Sil, et al.. (2010). 591 Berberine sensitizes TRAIL-induced apoptosis through proteasomemediated down-regulation of c-FLIP and Mcl-1 proteins. European Journal of Cancer Supplements. 8(7). 186–186. 4 indexed citations
12.
Lee, Chang‐Han, Eun-Sil Sung, Aeyung Kim, et al.. (2010). Engineering of a human kringle domain into agonistic and antagonistic binding proteins functioning in vitro and in vivo. Proceedings of the National Academy of Sciences. 107(21). 9567–9571. 32 indexed citations
13.
Sung, Eun-Sil, et al.. (2009). A novel agonistic antibody to human death receptor 4 induces apoptotic cell death in various tumor cells without cytotoxicity in hepatocytes. Molecular Cancer Therapeutics. 8(8). 2276–2285. 23 indexed citations
14.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Angéla Virone-Oddos Breakdown of academic impact, for papers by Katharina Jannasch Breakdown of academic impact, for papers by Gilda Rossoni Breakdown of academic impact, for papers by Anna Lyakisheva Breakdown of academic impact, for papers by Seung‐Oe Lim Breakdown of academic impact, for papers by Katharina Wartha Breakdown of academic impact, for papers by L D Apelgren Breakdown of academic impact, for papers by Yasuo Sekimori Breakdown of academic impact, for papers by Eric Kielhorn Breakdown of academic impact, for papers by Maya Dadiani
Rankless by CCL
2026